AAAAAA
Results:
1-25
|
Results: 25
Authors:
Soignet, SL
Frankel, SR
Douer, D
Tallman, MS
Kantarjian, H
Calleja, E
Stone, RM
Kalaycio, M
Scheinberg, DA
Steinherz, P
Sievers, EL
Coutre, S
Dahlberg, S
Ellison, R
Warrell, RP
Citation: Sl. Soignet et al., United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia, J CL ONCOL, 19(18), 2001, pp. 3852-3860
Authors:
Tallman, MS
Citation: Ms. Tallman, Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies, BLOOD REV, 15(3), 2001, pp. 133-142
Authors:
Nabhan, C
Mehta, J
Tallman, MS
Citation: C. Nabhan et al., The role of bone marrow transplantation in acute promyelocytic leukemia, BONE MAR TR, 28(3), 2001, pp. 219-226
Authors:
Kini, AR
Peterson, LC
Tallman, MS
Lingen, MW
Citation: Ar. Kini et al., Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid, BLOOD, 97(12), 2001, pp. 3919-3924
Authors:
Tallman, MS
Andersen, JW
Schiffer, CA
Appelbaum, FR
Feusner, JH
Ogden, A
Shepherd, L
Willman, C
Bloomfield, CD
Rowe, JM
Wiernik, PH
Citation: Ms. Tallman et al., All-trans-retinoic acid maintenance for acute promyelocytic leukemia, HEMAT BLOOD, 40, 2001, pp. 565-569
Authors:
Tallman, MS
Cassileth, PA
Wiernik, PH
Rowe, JM
Citation: Ms. Tallman et al., Treatment of older adults with acute myelogenous leukemia: Studies of the Eastern Cooperative Oncology Group (ECOG), HEMAT BLOOD, 40, 2001, pp. 639-643
Authors:
Bennett, CL
Stinson, TJ
Laver, JH
Bishop, MR
Godwin, JE
Tallman, MS
Citation: Cl. Bennett et al., Cost analyses of adjunct colony stimulating factors for acute leukemia: Can they improve clinical decision making, LEUK LYMPH, 37(1-2), 2000, pp. 65-70
Authors:
O'Donnell, MR
Appelbaum, FR
Baer, MR
Carabasi, MH
Coutre, SE
Erba, HP
Estey, E
Glenn, MJ
Kraut, EH
Maslak, P
Millenson, M
Miller, CB
Saba, HI
Stone, R
Tallman, MS
Citation: Mr. O'Donnell et al., NCCN Practice Guidelines for acute myelogenous leukemia, ONCOLOGY-NY, 14(11A), 2000, pp. 53-61
Authors:
Talpaz, M
Berman, E
Clift, RA
Copelan, EA
Emanuel, PD
Erba, HP
Glenn, MJ
Greenberg, PL
Jones, RJ
O'Brien, S
Saba, HI
Schilder, R
Snyder, DS
Soiffer, RJ
Tallman, MS
Wetzler, M
Ravandi-Kashani, F
Kantarjian, H
Talpaz, M
Citation: M. Talpaz et al., NCCN Practice Guidelines for chronic myelogenous leukemia, ONCOLOGY-NY, 14(11A), 2000, pp. 229-240
Authors:
Lee, S
Tallman, MS
Oken, MM
Cassileth, PA
Bennett, JM
Wiernik, PH
Rowe, JM
Citation: S. Lee et al., Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia, LEUKEMIA, 14(8), 2000, pp. 1345-1348
Authors:
Gordon, MS
Young, ML
Tallman, MS
Cripe, LD
Bennett, JM
Paietta, E
Longo, W
Gerad, H
Mazza, J
Rowe, JM
Citation: Ms. Gordon et al., Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia - A study of the Eastern Cooperative Oncology Group (ECOG), E5995, LEUK RES, 24(10), 2000, pp. 871-875
Authors:
Tallman, MS
Neuberg, D
Bennett, JM
Francois, CJ
Paletta, E
Wiernik, PH
Dewald, G
Cassileth, PA
Oken, MM
Rowe, JM
Citation: Ms. Tallman et al., Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience, BLOOD, 96(7), 2000, pp. 2405-2411
Authors:
Tallman, MS
Rowlings, PA
Milone, G
Zhang, MJ
Perez, WS
Weisdorf, D
Keating, A
Gale, RP
Geller, RB
Laughlin, MJ
Lazarus, HM
Luger, SM
McCarthy, PL
Rowe, JM
Saez, RA
Vowels, MR
Horowitz, MM
Citation: Ms. Tallman et al., Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission, BLOOD, 96(4), 2000, pp. 1254-1258
Authors:
Slack, JL
Willman, CL
Andersen, JW
Li, YP
Viswanatha, DS
Bloomfield, CD
Tallman, MS
Gallagher, RE
Citation: Jl. Slack et al., Molecular analysis and clinical outcome of adult APL patients with the type V PML-RAR alpha isoform: results from Intergroup protocol 0129, BLOOD, 95(2), 2000, pp. 398-403
Authors:
Tallman, MS
Andersen, JW
Schiffer, CA
Appelbaum, FR
Feusner, JH
Ogden, A
Shepherd, L
Rowe, JM
Francois, C
Larson, RS
Wiernik, PH
Citation: Ms. Tallman et al., Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome, BLOOD, 95(1), 2000, pp. 90-95
Authors:
Tallman, MS
Hakimian, D
Kopecky, KJ
Wheaton, S
Wollins, E
Foucar, K
Cassileth, PA
Habermann, T
Grever, M
Rowe, JM
Peterson, LC
Citation: Ms. Tallman et al., Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2 '-deoxycoformycin and prediction of early relapse, CLIN CANC R, 5(7), 1999, pp. 1665-1670
Authors:
Siegel, RS
Hakimian, D
Spies, W
Wollins, ER
Peterson, LC
Meyer, J
Tallman, MS
Citation: Rs. Siegel et al., Technetium-99M sulfur colloid scanning and correlative magnetic resonance imaging in patients with hairy cell leukemia and hypocellular bone marrow biopsies after 2-chlorodeoxyadenosine, LEUK LYMPH, 35(1-2), 1999, pp. 171-177
Authors:
Bennett, CL
Stinson, TJ
Tallman, MS
Stadtmauer, EA
Marsh, RW
Friedenberg, W
Lazarus, HM
Kaminer, L
Golub, RM
Rowe, JM
Citation: Cl. Bennett et al., Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia, ANN ONCOL, 10(2), 1999, pp. 177-182
Authors:
Bennett, CL
Bishop, MR
Tallman, MS
Somerfield, MR
Feinglass, J
Smith, TJ
Citation: Cl. Bennett et al., The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: Results from the 1997 American Society of Clinical Oncology survey, ANN ONCOL, 10(11), 1999, pp. 1355-1359
Authors:
Kleinman, MB
Wiley, EL
Guo, M
Rademaker, AW
Villa, M
Tallman, MS
Newman, SB
Gordon, LI
Winter, JN
Citation: Mb. Kleinman et al., Immunohistochemical detection of breast cancer cells in paired peripheral blood progenitor cell specimens collected after cytokine or cytokine and myelosuppressive chemotherapy, BONE MAR TR, 23(12), 1999, pp. 1297-1301
Authors:
Tallman, MS
Citation: Ms. Tallman, The thrombophilic state in acute promyelocytic leukemia, SEM THROMB, 25(2), 1999, pp. 209-215
Authors:
Tallman, MS
Peterson, LC
Hakimian, D
Gillis, S
Polliack, A
Citation: Ms. Tallman et al., Treatment of hairy-cell leukemia: Current views, SEM HEMATOL, 36(2), 1999, pp. 155-163
Authors:
Tallman, MS
Lee, S
Sikic, BI
Paietta, E
Wiernik, PH
Bennett, JM
Rowe, JM
Citation: Ms. Tallman et al., Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia - An Eastern Cooperative Oncology Group Pilot Study, CANCER, 85(2), 1999, pp. 358-367
Authors:
Advani, R
Saba, HI
Tallman, MS
Rowe, JM
Wiernik, PH
Ramek, J
Dugan, K
Lum, B
Villena, J
Davis, E
Paietta, E
Litchman, M
Sikic, BI
Greenberg, PL
Citation: R. Advani et al., Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC833 (Valspodar), BLOOD, 93(3), 1999, pp. 787-795
Authors:
Zhou, DC
Hallam, SJ
Lee, SJ
Klein, RS
Wiernik, PH
Tallman, MS
Robert, E
Citation: Dc. Zhou et al., Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells, CANCER RES, 58(24), 1998, pp. 5770-5776
Risultati:
1-25
|